Historical Grant

BBSRC ICURe Explore 2026: Closed £35,000 Market Exploration Grant Reference

You know that moment in a lab meeting when someone says, “This could be huge,” and everyone nods… and then you all go back to pipetting because nobody has time to figure out who would actually buy it, use it, approve it, or pay for it? That…

FindMyMoney.App
Published by FindMyMoney.App
Official source: Biotechnology and Biological Sciences Research Council (BBSRC)
💰 Funding Up to £35,000 total: up to £20,000 for the Entrepreneurial Lead salary and up to £15,000 for …
📅 Deadline Historical reference
🏛️ Source Biotechnology and Biological Sciences Research Council (BBSRC)

You know that moment in a lab meeting when someone says, “This could be huge,” and everyone nods… and then you all go back to pipetting because nobody has time to figure out who would actually buy it, use it, approve it, or pay for it? That’s the gap BBSRC ICURe Explore was built to close.

ICURe Explore 2026 was not a research grant in the traditional “more experiments, more data” sense. It was funding for a different kind of work: getting out of the building (politely, productively) to test whether a bioscience-based idea had a real market and a real customer problem behind it. Think of it as a structured reality check—with cash attached.

Status: Closed 2026 cycle

The official UKRI opportunity page lists BBSRC ICURe Explore 2026 as closed. It opened on 8 December 2025 and closed on 6 February 2026 at 11:59pm UK time. The UKRI programme overview and current opportunity search show no later BBSRC ICURe Explore round or next-round dates announced as of this page check. This is a historical reference, not a live application listing: the deadline below is the real closing date of the archived round, and its application route is closed.

The 2026 programme was designed for bioscience PhD students, researchers, and technicians who already had something promising—perhaps a tool, method, platform, assay, software, synthetic biology approach, or enabling technology—and needed evidence about its market. A therapeutic or diagnostic idea was not automatically in scope: UKRI excluded devices and therapeutics developed solely for a specific clinical endpoint, including diagnostics. A platform or alternative market beyond that clinical use could still fit the published scope. Not just a supervisor or collaborators. The outside world: clinicians, pharma, food producers, diagnostics labs, regulators, procurement teams, and the people who sign purchase orders.

Here’s the kicker: applicants had to have completed ICURe Discover. That prerequisite was doing applicants a favour. It meant they were not walking in cold—they were building on earlier training and momentum, and reviewers could assume they understood the basics of market exploration rather than treating “customer discovery” like an exotic new species.

At a Glance: ICURe Explore 2026 Key Facts

DetailInformation
Funding typeMarket exploration grant / commercialisation support programme
FunderBiotechnology and Biological Sciences Research Council (BBSRC), via UKRI
ProgrammeICURe Explore 2026
Total fund for the opportunity£420,000
Max awardUp to £35,000
What the money coversUp to £20,000 for the Entrepreneurial Lead’s salary and up to £15,000 for assumption testing, customer discovery, and business adviser support
Who can applyBioscience PhD students, researchers, and technicians
Eligible organisationsUK universities; BBSRC-funded institutes; UKRI-approved public sector research enterprises
Required prerequisiteCompleted ICURe Discover before applying; the Entrepreneurial Lead also needed organisational or funder approval and full-time availability
Deadline6 February 2026 at 11:59pm UK time; cycle closed
Opportunity statusClosed; historical reference
Official opportunity pagehttps://www.ukri.org/opportunity/bbsrc-innovation-to-commercialisation-of-university-research-icure-explore-2026/
Contacts[email protected], [email protected], [email protected]

What This Opportunity Actually Pays For (and Why That Matters)

The headline number—up to £35,000—was useful, but the structure is what made ICURe Explore unusually practical.

First, it included up to £20,000 for the Entrepreneurial Lead’s salary. Translation: someone could be paid to do the unglamorous, high-value work of talking to potential customers, mapping routes to market, and stress-testing assumptions. This mattered because commercial exploration is time-consuming in a way that doesn’t show up on a CV. Without dedicated time, it becomes “something I’ll do after I finish this experiment,” which is academic code for “never.”

Second, there was up to £15,000 for market discovery activities and business adviser support. That phrase can sound like consultant-speak, so let’s pin it down. Assumption testing is simply identifying what you are guessing—about the user, the problem, the performance requirements, the regulatory path, adoption barriers, pricing, competitors—and then gathering evidence to prove or disprove those guesses.

Customer discovery is the engine that powers that evidence. It might include travel to visit stakeholders, attending a targeted industry event (not the generic conference buffet circuit), developing simple prototypes or demos, paying for small bits of market research, or running tightly scoped validations.

In other words, ICURe Explore funds the work that turns “this is interesting science” into “this solves a painful problem for a defined group of people, and here’s proof.”

What ICURe Explore Is Not (So You Do Not Waste Your Time)

Let’s be blunt because deadlines are real: this is not a grant to extend your research project. If your plan is “run more experiments and then maybe someone will want it,” you’ll struggle.

It’s also not a blank cheque for building a polished product. ICURe Explore sits earlier than that. You’re testing demand, use-cases, and feasibility in the market sense—before you spend a year building something nobody asked for.

And it’s not a solo hero mission. Even if you’re the Entrepreneurial Lead, your project should show signs of being anchored in an institution that can support translation: tech transfer, business engagement, an innovation office, or a credible pathway to the next stage.

Who Was Eligible for the 2026 Cycle (with Real-World Fit Checks)

ICURe Explore 2026 was open to bioscience researchers in UK universities, BBSRC-funded institutes, and BBSRC-approved public sector research enterprises (PSREs). The published roles included PhD students, postdoctoral research associates, researchers in fellowships or group leader positions, and research technical professionals. The Entrepreneurial Lead had to receive a salary or stipend from an eligible organisation, complete ICURe Discover, obtain approval from the research organisation or funder, and commit for the programme from the week of the bootcamp. The programme described the lead’s participation as full time.

Teams comprised two to four people supporting the Entrepreneurial Lead. UKRI described a principal scientific advisor, a technology transfer representative or professional, and a business adviser; it strongly encouraged teams to name a business adviser. The technology transfer representative needed to attend the essential bootcamp sessions and options roundabout and support commercialisation work after the programme. The organisation also had to agree to the application before submission. These were substantive readiness conditions, not optional polish.

The project had to be biological in nature, interact with a biological entity, involve a biological process, or address a biological challenge. UKRI welcomed work across agriculture and food, healthy ageing, engineering biology, industrial biotechnology, and tools that underpin biological research. It gave priority to ideas building on earlier BBSRC or other UKRI grant support; applicants had to identify the relevant grant support, and PhD applicants basing an application on their PhD research had to name its funder. A project already taken through ICURe Explore could not be submitted again.

There was also an important clinical-scope boundary. UKRI said it would not accept medical or clinical devices and therapeutics developed solely for a specific endpoint clinical use, including diagnostics. The page gave other-market or platform applications as possible routes into scope, such as exploring livestock use for a technology initially associated with human health. Anyone uncertain about fit was advised to contact the programme team.

If you’re assessing the archived criteria for a future opportunity, ask whether you can point to a specific group with a recurring, expensive, regulated, risky, or time-draining problem—and explain how the bioscience idea might improve its situation. Fit also depended on the published exclusions and team prerequisites; a persuasive market story alone could not replace them.

The programme could suit PhD students with an invention embedded in a thesis, postdoctoral researchers or staff working on a platform technology, and technicians who understood operational bottlenecks in sample handling, quality control, workflows, instrument uptime, or compliance. A finished company was not required. The central task was to gather credible market evidence, while staying within the scientific and eligibility boundaries UKRI set.

The Big Idea: Market Exploration as a Scientific Method

If “commercialisation” makes you itch, reframe it. ICURe Explore is basically applying the scientific method to the market.

  • Your “hypothesis” is your value proposition.
  • Your “experimental design” is your interview plan and assumption tests.
  • Your “results” are patterns across stakeholders, not p-values.
  • Your “conclusion” is a clearer route to impact—whether that’s licensing, a spinout, partnership, or even a decision to park the idea.

This is why the programme is worth your time even if you don’t end up founding a company. The skills travel with you.

Insider Tips for a Winning ICURe Explore Application

1) Write your assumptions like you mean it

Most applicants hide their assumptions in vague language: “There is significant demand for…” No. List the assumptions plainly and make them testable. For example: “Quality managers in mid-size biotech CDMOs will pay £X per year to reduce contamination events by Y%” is scary-specific—and that’s exactly why it’s useful.

2) Pick a customer segment and commit

You can always expand later. For Explore, choosing “healthcare” or “agriculture” is like choosing “planet Earth.” Instead, narrow: hospital microbiology labs, dairy processors, insect protein producers, cell therapy manufacturers, plant breeders, water utilities. Reviewers want focus because focus is how you learn quickly.

3) Make your Entrepreneurial Lead role look real, not ceremonial

The funding explicitly supports the Entrepreneurial Lead salary. Use that fact. Explain what that person will do week-to-week: number of interviews, stakeholder mapping, iteration cycles, validation activities. Make it feel like a job plan, not a title.

4) Show you understand adoption friction

In bioscience, the barrier is rarely “does it work?” It’s “can we validate it, integrate it, certify it, train staff on it, and justify buying it?” Address practical blockers early: regulatory classification, procurement cycles, compatibility with existing workflows, sample requirements, cold chain constraints, data governance, IP position.

5) Treat interviews as an experiment, not a chat

A strong customer discovery plan doesn’t say “we’ll talk to industry.” It says how many conversations, with whom, and what you’re trying to learn from each cohort. Mix your stakeholders: end users, buyers, influencers, and gatekeepers (hello, compliance and IT).

6) Budget like an adult, not like a wish list

The Explore budget categories are clear: salary plus customer discovery and testing costs. Build a budget that matches your learning goals. If travel is central, explain why in-person meetings are necessary (often true in regulated settings). If you need a prototype, keep it minimal and tied directly to validation.

7) Build a bridge to “what next”

Even if the programme doesn’t demand a full commercial plan, your application should hint at the next stepping stone: licensing discussions, seed funding, an accelerator, a translational grant, an industrial partner. You’re not promising a unicorn. You’re showing momentum and direction.

2026 Application Timeline: What the Closed Cycle Required

For the closed 2026 cycle, applicants worked backwards from the 6 February 2026 (23:59) deadline. The official page recorded an opening date of 8 December 2025, followed by a welcome call on 2 March 2026, bootcamp sessions on 4 to 5 March 2026 and 9 to 10 March 2026, and an options roundabout on 10 to 11 June 2026. Those dates describe the completed cohort; they are not a schedule for a new round.

For a future announcement, the useful planning lesson is to have the core narrative stable well before the closing date: what the problem is, who has it, why they care, and what the team will do during Explore to test the riskiest assumptions. Pressure-test the plan with people outside the lab—innovation office staff, an industry contact, or someone who has done ICURe before. If they cannot repeat the value proposition back, the application needs work.

In the final weeks before a future closing date, tighten the scope, align the budget with activities, and make sure the Entrepreneurial Lead’s time commitment is credible. In the final week, do a compliance pass—eligibility, prerequisite completion (ICURe Discover), attachments, formatting, and internal sign-off if your organisation requires it. Submit early enough to resolve portal or sign-off problems.

Application Information: What the Closed Round Required

UKRI’s opportunity page linked applicants to Innovate UK Business Connect for the application. The published page does not enumerate a universal attachment checklist, so this archive should not be read as a definitive list of mandatory forms or documents. What it does state is useful for understanding the substance the 2026 proposal had to establish.

Applicants needed to explain the bioscience idea or product and its market opportunity, show how the team would test value propositions through market engagement, and identify the previous BBSRC or other UKRI grant underpinning the research. A PhD applicant whose proposal relied on PhD research had to state the PhD funder. The organisation had to agree to the application, including the lead’s ability to commit full time. The Entrepreneurial Lead and associated science advisor were also required to participate in scheduled individual video interviews during competitive assessment.

A clear application plan would therefore connect a defined customer segment and problem to specific assumptions, conversations, and decision points. It should show how the work would investigate supply-chain participants, regulators, customers, and competitors, and why each activity was necessary to evaluate market potential. The official programme supported assumption testing and customer discovery; the funding was not described as a general research-extension budget.

For a historical review, distinguish these published requirements from sensible preparation advice. A budget mapping costs to learning milestones, a concise project explanation, and internal sign-off records are practical ways to make a proposal coherent, but the closed UKRI page did not label each of those items as a separate required attachment. The application portal and its guidance were the source of any form-specific instructions for that round.

What Makes an Application Stand Out to Reviewers

Successful ICURe Explore applications feel grounded in reality. Not cynical—just evidence-based.

Reviewers tend to respond well when the problem is urgent and expensive, the customer is identifiable, and the proposed discovery work is designed to reduce the biggest uncertainties fast. They also like teams who don’t confuse “market size” with “market access.” You can claim a billion-pound market in one sentence; getting a first buyer is the hard part. Show you understand that.

A standout application also respects the difference between an invention and a product. Your technology might be brilliant, but the programme is about fit: fit with workflows, incentives, regulation, and purchasing behaviour. If you demonstrate you’re ready to learn—not just to persuade—you’ll read as fundable.

Common Mistakes to Avoid (and How to Fix Them)

Mistake 1: Trying to serve everyone. Fix: Pick one beachhead market. Name it. Describe it. Make the first use-case painfully specific.

Mistake 2: Writing like a paper instead of a plan. Fix: Replace literature-style background with a clear set of assumptions, risks, and tests. Market exploration is not a review article.

Mistake 3: Confusing interest with commitment. Fix: In interviews, don’t ask “Would you use this?” Ask what they do now, what it costs them, what happens when it fails, and what would make them switch.

Mistake 4: Ignoring the buyer. Fix: End users love things. Buyers buy outcomes. Identify who holds the budget and what they’re measured on.

Mistake 5: Overbuilding too early. Fix: Build the smallest demo that answers a question. “Can it work in their setting?” beats “Can we make it pretty?”

Mistake 6: Forgetting IP and freedom to operate. Fix: You don’t need a full patent strategy in Explore, but you should show you’ve spoken to the right people internally and understand what’s protectable and what might be crowded.

Frequently Asked Questions

Do I need to be a PI to apply?

No. Eligible Entrepreneurial Leads included PhD students, technicians, postdoctoral researchers, fellows, and group leaders whose salary or stipend came from an eligible organisation. They still had to complete ICURe Discover, secure organisational or funder approval, and commit full time for the programme. The official page also described a supporting team of two to four people.

Is this only for UK universities?

The 2026 call named UK universities, BBSRC-funded institutes, and BBSRC-approved public sector research enterprises (PSREs). Confirm the host’s status against the exact call wording; the 2026 call is closed.

What does completed ICURe Discover mean in practice?

It means you’ve previously gone through the ICURe Discover stage. If you’re not sure whether your participation counts as “completed,” ask using the contacts listed on the opportunity or your local programme lead before you spend hours drafting.

Was the £35,000 a general research grant?

No. UKRI described up to £20,000 for the Entrepreneurial Lead’s salary and up to £15,000 for assumption testing, customer discovery, and business adviser support. The opportunity was designed for market exploration rather than a general programme of laboratory research. The official page does not promise that any particular lab cost would be eligible, so applicants needed to follow the application guidance and connect proposed costs to the stated market-discovery purpose.

What is customer discovery, really?

It’s structured learning through conversations and evidence gathering with the people involved in using, buying, approving, or recommending your innovation. You’re looking for patterns: repeated pain points, constraints, purchasing triggers, and deal-breakers.

How competitive is it?

Programmes like this tend to be competitive because the value is high and the funding is targeted. The upside is that a focused, well-designed exploration plan can beat a flashier technology with a fuzzy market story.

Could the programme lead to a spinout or licensing route?

UKRI said participants could access further support through ICURe Exploit to spin out or licence technology. That was a possible next step, not a guaranteed outcome or promise of follow-on funding. The purpose of Explore was to test the market and help teams consider suitable commercialisation routes based on evidence.

Who do I contact with questions?

You’ve got three listed contacts: [email protected], [email protected], and [email protected]. Use them—asking an eligibility question early is faster than rewriting an application late.

How the 2026 Cycle Accepted Applications

The 2026 route was through Innovate UK Business Connect, as linked from the official UKRI page. Before that cycle closed, applicants needed to confirm two gatekeepers: their organisation was eligible, and they had completed ICURe Discover. The application also needed organisational agreement, including the Entrepreneurial Lead’s ability to commit to the programme full-time.

The application plan should have covered the customer segment, the problem, current alternatives, and what would have to be true for adoption. It should also have explained the bioscience innovation, the proposed market exploration, the team’s roles, and the previous BBSRC or other UKRI grant underpinning the work. If the proposal was based on PhD research, the official guidance asked applicants to identify the PhD funder.

The customer discovery plan needed to show how the team would test value propositions through market engagement, including research with supply-chain participants, regulators, customers, and competitors. A concrete target for stakeholder conversations, a way to capture learning, and decision points for changing course would make the plan more credible than a promise to “talk to industry.”

Finally, the budget needed to map directly to learning milestones. The official award structure allowed up to £20,000 for the Entrepreneurial Lead’s salary and up to £15,000 for market discovery activities and business adviser support. A cost that did not buy useful information or support the required programme participation was difficult to justify.

The 2026 application window has ended. For any future BBSRC ICURe announcement, use the organisation’s current UKRI opportunity page and its linked Innovate UK Business Connect application route rather than relying on this archived cycle. The official 2026 reference remains here: https://www.ukri.org/opportunity/bbsrc-innovation-to-commercialisation-of-university-research-icure-explore-2026/

Next step
Check official source